In lung cancer tissues, METTL3 can trigger the splicing of the precursor miR-143-3p to generate mature miR-143-3p, which targets three binding sites in the vasohibin (VASH) 1 promoter and inhibits its expression. This evidence concerns the gene METTL3 and lung cancer.